The finding arose from long-term follow-up of patients who received human growth hormone that was taken from brain tissue of deceased donors, but the risk is very low – and you can’t “catch” it like a virus.
A recent review has found that almost three in 10 adult hospital patients in high-income countries may have the deficiency.
A new trial is looking for chemical markers in the breath of people with silicosis. A second project will test drugs that may help lung scarring.
The groundbreaking identification of a specific T-cell receptor in healthy people without lupus has the potential to treat not only that disease, but approximately 100 autoimmune diseases known to have a similar pathology.
The TGA has just approved a vaccine against RSV for Australians over 60. Here’s where protection is up to for the youngest children, who are also at risk from the virus.
A recent study from Sweden found people with a history of chronic stress or depression had a heightened risk of developing Alzheimer’s disease.
Snake envenomation remains a significant health challenge in the ASEAN region, but the development of a universal antivenom holds great promise in mitigating its impact.
The drug donanemab is being hailed as a turning point in the fight against Alzheimer’s, following a global trial that confirms it can slow cognitive decline.
It's been around for a decade now — but cultured meat still faces some huge hurdles.
A new research program will target biological causes and possible treatments, including anti-psychotic drugs, brain stimulation and hormones.
Researchers are investigating the eventual fate and function of food-derived bacteria, and the role they play in shaping our gut health and microbiome.
The Victorian Heart Hospital, which opened in February, brings researchers to where the patients are, and already there’s a real buzz about the place.
The Monash University team that developed the world’s first low FODMAP diet for IBS has produced its first cookbook, incorporating gourmet recipes and evidence-based dietary tips.
On a new episode of Monash University’s “What Happens Next?” podcast, meet the healthcare providers and advocates working tirelessly to ensure that we don't lose ground in the global fight for reproductive rights.
This week on Monash University's “What Happens Next?” podcast, meet the change-makers on the front lines of food.
Season 7 of Monash University’s podcast returns from hiatus with an investigation into food security. How will we feed more people than ever on an ever-warming planet?
The Omicron strain is driving a rapid increase in China, and is quicker to transmit than other variants.
As Alzheimer’s cases grow, scientists have been deep in debate over its causes. Now, with treatments are on the horizon, the new race is to ready the health system.
It’s hoped new research will raise awareness among reproductive-aged women and men of the importance of optimal health during the preconception period.
The country ranks fifth in the Western Pacific, with 4.4 million adults diagnosed with diabetes in 2021, but there’s a way forward to combat the disease.
It’s a long-term treatment – people having allergen immunotherapy typically notice improved symptoms after six to 12 months.
German doctors have reported success in treating patients with severe lupus, using cell treatments like those used for some forms of blood cancer.
Professor Jamie Rossjohn is internationally recognised for using structural biology to investigate how T cells can respond to viral infections or cause autoimmunity. Now, he's been named a fellow of the oldest science academy in the world.
Dummy text